Equities

Surgery Partners Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Surgery Partners Inc

Actions
  • Price (EUR)12.90
  • Today's Change0.00 / 0.00%
  • Shares traded165.00
  • 1 Year change-47.56%
  • Beta1.9496
Data delayed at least 15 minutes, as of Feb 17 2026 07:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments270196283
Total Receivables, Net579496456
Total Inventory887571
Prepaid expenses363131
Other current assets, total1469779
Total current assets1,119895921
Property, plant & equipment, net1,3841,2241,156
Goodwill, net5,0684,3264,137
Intangibles, net465542
Long term investments215184190
Note receivable - long term------
Other long term assets58103144
Total assets7,8906,8776,682
LIABILITIES
Accounts payable209172152
Accrued expenses258220190
Notes payable/short-term debt000
Current portion long-term debt/capital leases1017363
Other current liabilities, total575889
Total current liabilities624523493
Total long term debt3,2692,7022,559
Total debt3,3702,7752,622
Deferred income tax39----
Minority interest1,8461,3751,285
Other liabilities, total322290347
Total liabilities6,1004,8904,684
SHAREHOLDERS EQUITY
Common stock1.301.301.30
Additional paid-in capital2,5212,4982,478
Retained earnings (accumulated deficit)(737)(569)(557)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total4.805876
Total equity1,7901,9871,998
Total liabilities & shareholders' equity7,8906,8776,682
Total common shares outstanding127127126
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.